在腦血管病人的恢復(fù)期,除了進行必要的理療和功能鍛煉外,配合應(yīng)用腦代謝活化藥物能有效提高腦細胞對氧氣和葡萄糖的利用,改善因缺血缺氧導(dǎo)致的神經(jīng)功能障礙,從而促進腦功能的全面恢復(fù)。
| 中文名稱 | 英文名稱 | CAS號 | 化學(xué)式 |
|---|---|---|---|
| 阿米君 | almitrine | 27469-53-0 | C26H29F2N7 |
| 阿尼西坦 | aniracetam | 72432-10-1 | C12H13NO3 |
| 鈣離子 | Calcium Cation | 14127-61-8 | Ca+2 |
| 鈣 | Calcium | 7440-70-2 | Ca |
| 酒石酸卡巴拉汀 | rivastigmine tartrate | 129101-54-8 | C4H6O6*C14H22N2O2 |
| 蘿巴新 | (-)-Ajmalicine hydrochloride | 4373-34-6 | C21H24N2O3*ClH |
| 蘿巴新 | racemic ajmalicine | 483-04-5 | C21H24N2O3 |
| 莫西賽利 | thymoxamine | 54-32-0 | C16H25NO3 |
| 艾地苯醌 | Idebenone | 58186-27-9 | C19H30O5 |
| 考拉西坦 | Coluracetam | 135463-81-9 | C19H23N3O3 |
| 硝唑芬酮 | nizofenone | 54533-85-6 | C21H21ClN4O3 |
| 鹽酸吡硫醇 | Pyritinol dihydrochloride | 10049-83-9 | C16H22Cl2N2O4S2 |
| 益智酰胺 | etiracetam | 33996-58-6 | C8H14N2O2 |
| 溴長春胺 | bromovinamine | 57475-17-9 | C21H25BrN2O3 |
| 洛米茶堿 | 7-(5-keto-hexyl)-1,3-dimethylxanthine | 10226-54-7 | C13H18N4O3 |
| 普羅潘非林 | propentofylline | 55242-55-2 | C15H22N4O3 |
| 普拉西坦 | pramiracetam | 68497-62-1 | C14H27N3O2 |
| 恩他卡朋 | entacapone | 130929-57-6 | C14H15N3O5 |
| 布瓦西坦 | brivaracetam | 357336-20-0 | C11H20N2O2 |
| 富馬酸溴長春胺 | Brovincamine fumarate | 84964-12-5 | C4H4O4*C21H25BrN2O3 |
| 奧拉西坦 | oxiracetam | 62613-82-5 | C6H10N2O3 |
| 奈非西坦 | nefiracetam | 77191-36-7 | C14H18N2O2 |
| 多萘哌齊堿 | donepezil | 120014-06-4 | C24H29NO3 |
| 四氫鴨腳木堿 | (+/-)-tetrahydroalstonine | 6474-90-4 | C21H24N2O3 |
| 吡硫醇 | Pyritinol | 1098-97-1 | C16H20N2O4S2 |
| 吡拉西坦 | 2-oxo-1-pyrrolidine acetamide | 7491-74-9 | C6H10N2O2 |
| 雙芬麥蘭 | bifemelane | 90293-01-9 | C18H23NO |
| 利凡斯的明 | rivastigmin | 123441-03-2 | C14H22N2O2 |
| 依昔苯酮 | 2,3,4,3',4',5'-hexahydroxybenzophenone | 52479-85-3 | C13H10O7 |
| 3-(1-(二甲基氨基)乙基)苯基 乙基(甲基)氨基甲酸酯 | (-)-<3-<1'-(Dimethylamino)ethyl>phenyl>-N-ethyl-N-methylcarbamat | 105601-20-5 | C14H22N2O2 |
| 2,3,4,9-四氫-3-(甲基氨基)-1H-咔唑-6-甲酰胺 | 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole | 147009-08-3 | C14H17N3O |
| —— | 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylicacid, 9-bromo-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-12-hydroxy-, methylester, (12R,13aR,13bR)-rel- | 57475-17-9 | C21H25BrN2O3 |
| —— | [(3R,6S,12S,15R,16R)-7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate | 11042-64-1 | C40H58O4 |
| —— | Encephabol | 60479-98-3 | C16H24Cl2N2O5S2 |
| —— | Oryzanol A | 11042-64-1 | C40H58O4 |
| —— | S-(2-aminoethyl)isothiouronium bromide hydrobromide | 2141-04-0 | 2BrH*C3H9N3S |
| —— | Tetrahydro-Alstonin | 483-03-4 | C21H24N2O3 |
| —— | Tetrahydroalstonin | 483-03-4 | C21H24N2O3 |
| —— | 19α-methyl-18-oxa-yohimb-16-ene-16-carboxylic acid methyl ester | 483-03-4 | C21H24N2O3 |
| —— | <i>rac</i>-19β-methyl-(15β)-18-oxa-yohimb-16-ene-16-carboxylic acid methyl ester | 483-03-4 | C21H24N2O3 |
| —— | 19β-methyl-(20α)-18-oxa-yohimb-16-ene-16-carboxylic acid methyl ester | 483-03-4 | C21H24N2O3 |
| —— | Ajmalicin | 483-03-4 | C21H24N2O3 |
| —— | (+)-rauniticine | 483-03-4 | C21H24N2O3 |
| —— | Alstonine, 3,4,5,6-tetrahydro-, (3.α.)- | 483-03-4 | C21H24N2O3 |
| —— | ajmalicine | 483-03-4 | C21H24N2O3 |
| —— | (-)-<3-<1'-(Dimethylamino)ethyl>phenyl>-N-ethyl-N-methylcarbamat-(+)-L-tartrat | 129101-54-8 | C4H6O6*C14H22N2O2 |
| —— | pyrithioxin dihydrochloride | 10049-83-9 | C16H20N2O4S2*2ClH |
| —— | calcium | 7440-70-2 | Ca |
| —— | (c)(3/4)-Oryzanol;Gamma Oryzanol | 11042-64-1 | C40H58O4 |